Helicobacter pylori serology in autoimmune diseases - Fact or fiction?

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 5, 2013, Pages 1075-1082

  Ram, Maya ^a   Barzilai, Ori ^a   Shapira, Yinon ^a   Anaya, Juan Manuel ^b   Tincani, Angela ^c   Stojanovich, Ljudmila ^d   Bombardieri, Stefano ^e   Bizzaro, Nicola ^f   Kivity, Shaye ^a   Levin, Nancy Agmon ^a   Shoenfeld, Yehuda ^a,g  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Bezhanijska Kosa University Medical Center   (Serbia)

^e UNIVERSITY OF PISA   (Italy)

^f Ospedale S Antonio   (Italy)

^g TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibodies; Autoantibodies; Autoimmune diseases; Autoimmunity; Helicobacter pylori; Infection

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; GASTROINTESTINAL DISEASE; GIANT CELL ARTERITIS; HELICOBACTER PYLORI; HUMAN; INFECTION; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SEROLOGY; SYSTEMIC SCLEROSIS; THROMBOPHILIA;

ANTIBODIES, BACTERIAL; ANTIGEN-ANTIBODY REACTIONS; AUTOIMMUNE DISEASES; BLOOD CHEMICAL ANALYSIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 84882282125     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0477     Document Type: Article

References (54)

1. Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME. The auto immunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008;31:325-30.
2. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr Med Assoc J 2008;10:8-12.
3. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity-friends or foes ? Trends Immunol 2009;30:409-14.
4. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-20.
5. Fae KC, da Silva DD, Oshiro SE, Tanaka AC, Pomerantzeff PM, Douay C, et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 2006;176:5662-70.
6. Getts MT, Miller SD. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections. Clin Exp Immunol 2010;160:15-21.
7. Goodwin CS, Worsley BW. Microbiology of Helicobacter pylori. Gastroenterol Clin North Am 1993;22:5-19.
8. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
9. Hasni S, Ippolito A, Illei GG. Helicobacter pylori and autoimmune diseases. Oral Dis 2011;17:621-7.
10. Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, et al. Molecular mimicry between Helicobacter pylori antigens and H + , K + -adenosine triphosphatase in human gastric autoimmunity. J Exp Med 2003;198:1147-56.
11. Yamanishi S, Iizumi T, Watanabe E, Shimizu M, Kamiya S, Nagata K, et al. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 2006;74:248-56.
12. Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y, et al. Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol 2008;26(1 Suppl 48):S27-32.
13. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 2007;167: 821-7.
14. Emilia G, Luppi M, Zucchini P, Morselli M, Potenza L, Forghieri F, et al. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. Blood 2007;110:3833-41.
15. Franchini M, Veneri D. Helicobacter pylori-associated immune thrombocytopenia. Platelets 2006;17:71-7.
16. Shoenfeld Y , Cervera R, Gershwin ME, editors. Diagnostic criteria in autoimmune diseases. Totowa: Humana Press, 2008.
17. Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious ? A preliminary report. Ann N Y Acad Sci 2007;1108:567-77.
18. Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N, et al. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci 2009;1173:640-8.
19. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008;134:306-23.
20. Rain JC, Selig L, De Reuse H, Battaglia V, Reverdy C, Simon S, et al. The protein-protein interaction map of Helicobacter pylori. Nature 2001;409:211-5.
21. Weeks DL, Eskandari S, Scott DR, Sachs G. A H + -gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 2000;287:482-5.
22. Fan X, Gunasena H, Cheng Z, Espejo R, Crowe SE, Ernst PB, et al. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J Immunol 2000;165:1918-24.
23. Nilius M, Malfertheiner P. Helicobacter pylori enzymes. Aliment Pharmacol Ther 1996;10(Suppl 1):65-71.
24. Portal-Celhay C, Perez-Perez GI. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci (Lond) 2006;110:305-14.
25. Robinson K, Kenefeck R, Pidgeon EL, Shakib S, Patel S, Polson RJ, et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 2008;57:1375-85.
26. Fan XG, Chua A, Fan XJ, Keeling PW. Increased gastric production of interleukin-8 and tumour necrosis factor in patients with Helicobacter pylori infection. J Clin Pathol 1995;48:133-6.
27. Tombola F, Morbiato L, Del Giudice G, Rappuoli R, Zoratti M, Papini E. The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J Clin Invest 2001;108:929-37.
28. Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol 2005;21:653-9.
29. Van Doorn LJ, Figueiredo C, Megraud F, Pena S, Midolo P, Queiroz DM, et al. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 1999;116:823-30.
30. Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S. H pylori infection in patients with Behcet ' s disease. World J Gastroenterol 2007;13:2983-5.
31. Machet L, Vaillant L, Machet MC, Buchler M, Lorette G. Schonlein-Henoch purpura associated with gastric Helicobacter pylori infection. Dermatology 1997;194:86.
32. Kalabay L, Fekete B, Czirjak L, Horvath L, Daha MR, Veres A, et al. Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 2002;7:250-6.
33. Aragona P, Magazzu G, Macchia G, Bartolone S, Di Pasquale G, Vitali C, et al. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjogren ' s syndrome. J Rheumatol 1999;26:1306-11.
34. Grossman C, Dovrish Z, Shoenfeld Y, Amital H. Do infections facilitate the emergence of systemic sclerosis ? Autoimmun Rev 2011;10:244-7.
35. Radic M, Martinovic Kaliterna D, Bonacin D, Morovic Vergles J, Radic J. Correlation between Helicobacter pylori infection and systemic sclerosis activity. Rheumatology (Oxford) 2010;49:1784-5.
36. Durazzo M, Rosina F, Premoli A, Morello E, Fagoonee S, Innarella R, et al. Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis. World J Gastroenterol 2004;10:3179-81.
37. Bassi V, Santinelli C, Iengo A, Romano C. Identification of a correlation between Helicobacter pylori infection and Graves ' disease. Helicobacter 2010;15:558-62.
38. Sagi L, Baum S, Agmon-Levin N, Sherer Y, Katz BS, Barzilai O, et al. Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature. Autoimmun Rev 2011;10:527-35.
39. El Miedany YM, Baddour M, Ahmed I, Fahmy H. Sjogren ' s syndrome: concomitant H. pylori infection and possible correlation with clinical parameters. Joint Bone Spine 2005;72:135-41.
40. Theander E, Nilsson I, Manthorpe R, Jacobsson LT, Wadstrom T. Seroprevalence of Helicobacter pylori in primary Sjogren ' s syndrome. Clin Exp Rheumatol 2001;19:633-8.
41. Strachan DP. Hay fever, hygiene, and household size. Br Med J 1989;299:1259-60.
42. Zaccone P, Fehervari Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003;33:1439-49.
43. Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 2002;76:12097-111.
44. Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M. Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry 1966;29:60-8.
45. Krause I, Anaya JM, Fraser A, Barzilai O, Ram M, Abad V, et al. Anti-infectious antibodies and autoimmune-associated auto antibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci 2009;1173:633-9.
46. Ram M, Anaya JM, Barzilai O, Izhaky D, Porat Katz BS, Blank M, et al. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev 2008;7:621-5.
47. Ohkusa T, Nomura T, Sato N. The role of bacterial infection in the pathogenesis of inflammatory bowel disease. Intern Med 2004;43:534-9.
48. Vare PO, Heikius B, Silvennoinen JA, Karttunen R, Niemela SE, Lehtola JK, et al. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scand J Gastroenterol 2001;36:1295-300.
49. Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012;35:469-76.
50. Kelly D, Conway S, Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 2005;26:326-33.
51. Shapira Y, Agmon-Levin N, Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010;34:J168-77.
52. Gavalas E, Kountouras J, Deretzi G, Boziki M, Grigoriadis N, Zavos C, et al. Helicobacter pylori and multiple sclerosis. J Neuroimmunol 2007;188:187-9.
53. Li W, Minohara M, Su JJ, Matsuoka T, Osoegawa M, Ishizu T, et al. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol 2007;184:227-31.
54. Sawalha AH, Schmid WR, Binder SR, Bacino DK, Harley JB. Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. J Rheumatol 2004;31:1546-50.